Skip to main content
Premium Trial:

Request an Annual Quote

Make Them Glow

Nanoparticles dubbed 'NanoFlares,' developed by Northwestern University researchers, may eventually be able to help clinicians detect circulating tumor cells in patients' blood.

As Northwestern's Shad Thaxton and colleagues report in the Proceedings of the National Academy of Sciences, they devised gold nanoparticles that can attach to certain cancer molecules based on their genetic markers and glow. The nanoparticles contain a monolayer of single-stranded DNA that has a 3' thiol that's complementary to mRNA for the target gene of interest. That recognition sequence of the ssDNA is prehybridized to a short DNA complement that contains a fluorescent reporter. That fluorescence is quenched when the molecule close to the gold molecule, but when the target mRNA binds that sequence, the reporter is displaced and glows.

As MIT's Technology Review notes, Thaxton and colleagues were able to use this approach to identify breast cancer cells that had been added to a sample of human blood, adding that the next step is to see whether this approach and also find such cells in samples from patients themselves.

"The ability to detect and quantify live patient-derived CTCs will provide vital information both in the study of cancer metastasis and the application of personalized medicine," the researchers say in PNAS.


Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.